home

programs

directory by group

resources by island

links

contact us

National HIV/AIDS Clinicians' Consultation Center

U.S. State and Jurisdiction Information

Country and Region Information

 


d4T (Stavudine, Zerit)

 

ABT-378/Ritonavir Plus Stavudine and Lamivudine for the Treatment of Antiretroviral-Naive Adults with HIV-1 Infection:  48-Week Results (PDF)

Comparison of Twice-Daily Stavudine Plus Once-Or Twice-Daily Didanosine and Nevirapine in Early Stages of HIV infection:  The Scan Study (PDF)

Concentrations of Nevirapine, Lamivudine and Stavudine in Semen of HIV-1-Infected Men (PDF)

d4T (Stavudine, Zerit), Various Languages

Dose-Ranging, Randomized, Clinical Trial of Atazanavir with Lamivudine and Stavudine in Antiretroviral-Naive Subjects:  48-Week Results (PDF)

Granulocyte-Macrophage Colony-Stimulating Factor Enhances Viral Load in Human Brain Tissue:  Amelioration with Stavudine (PDF)

HIV Drug Stavudine (Zerit, d4T) and Symptoms Mimicking Guillain Barre Syndrome (PDF)

Increased Risk of Lipoatrophy Under Stavudine in HIV-1-Infected Patients:  Results of A Substudy from A Comparative Trial (PDF)

Low Efficacy and High Frequency of Adverse Events in a Randomized Trial of the Triple Nucleoside Regimen Abacavir, Stavudine and Didanosine (PDF)

Low efficacy and High Frequency of Adverse Events in a Randomized Trial of the Triple Nucleoside Regimen Abacavir, Stavudine and Didanosine (PDF)

Monitoring of Didanosine and Stavudine Intracellular Trisphosphorylated Anabolite Concentrations in HIV-Infected Patients (PDF)

Significant Levels of Intracellular Stavudine Triphosphate Are Found in HIV-Infected Zidovudine-Treated Patients (PDF)

Zerit®  (stavudine, d4T)

Back to HIV Medication Information
Back to Non-English Information

 

home

programs

directory by group

resources by island

links

contact us

National HIV/AIDS Clinicians' Consultation Center

U.S. State and Jurisdiction Information

Country and Region Information

 


Comments/questions about this site to: Kevin Patrick
Site and banner created by David Flynn, UH Manoa